Home > Income Statement > CONCORD BIOTECH

CONCORD BIOTECH
Revenue

    Back to Income Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,017 Cr₹853 Cr₹71 Cr₹617 Cr₹5,123 Cr

What is the latest Revenue of CONCORD BIOTECH ?

The latest Revenue ratio of CONCORD BIOTECH is ₹1,017 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,017 Cr
Mar2024₹853 Cr
Mar2023₹71 Cr
Mar2022₹617 Cr
Mar2021₹5,123 Cr

How is Revenue of CONCORD BIOTECH Trending?

Years Revenue % Change
Mar2025 ₹1,017 Cr
19.20
Mar2024 ₹853 Cr
1,096.71
Mar2023 ₹71 Cr
-88.44
Mar2022 ₹617 Cr
-87.96
Mar2021 ₹5,123 Cr -

Compare Revenue of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹14,757.5 Cr -6% -6.7% -24.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,370.0 Cr 1.2% 5.5% 0.3% Stock Analytics
DIVIS LABORATORIES ₹168,802.0 Cr -1.8% -3.1% 8.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,841.0 Cr -2% 2.8% 19.2% Stock Analytics
CIPLA ₹121,481.0 Cr -0.7% -8.6% 2.7% Stock Analytics
DR REDDYS LABORATORIES ₹102,220.0 Cr -1.5% -4.3% 2.5% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-6%

-6.7%

-24.8%

SENSEX

-0.1%

0.6%

9.8%


You may also like the below Video Courses